|
Dilaudid-hpDrug - Dilaudid-hp The trade name of the product as shown on the labeling.
Dosage -
INJECTABLE; INJECTION
Active Ingredient(s) -
Hydromorphone Hydrochloride
Strength -
250MG/VIAL
Applicant -
ABBOTT
New Drug Application (NDA) Number -
019034
Product Number -
002
Therapeutic Equivalence (TE) Code -
Approval Date -
Aug 4, 1994
Reference Listed Drug (RLD) -
Yes
Type -
RX
Applicant Full Name -
Abbott Laboratories Pharmaceutical Products Div
Dilaudid-hp
Reserpine And Hydroflumethiazide 50mg;0.125mg Tablet; Oral
Reserpine And Hydroflumethiazide 50mg;0.125mg Tablet; Oral Salutensin 50mg;0.125mg Tablet; Oral Salutensin-demi 25mg;0.125mg Tablet; Oral Palladone 12mg Capsule, Extended Release; Oral Palladone 16mg Capsule, Extended Release; Oral Palladone 24mg Capsule, Extended Release; Oral Palladone 32mg Capsule, Extended Release; Oral Dilaudid-hp 10mg/ml Injectable; Injection Dilaudid-hp 250mg/vial Injectable; Injection NewDrugInformation |